🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
2 different formulations and 4 different single doses of tafamidis will be ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-28
Trial ID
NCT03662191
Treatments Being Tested
Controlled studies investigating the effects of vitamin E or H2 water or co...
Status
Unknown
Location
Augusta Victoria Hospital
Start Date
2019-07-06
Trial ID
NCT04713332
Treatments Being Tested
The purpose of this study was to confirm the preliminary evidence from earl...
Status
Completed
Location
University of Chicago Medical Center .
Start Date
2018-07-20
Trial ID
NCT03512197
Treatments Being Tested
The goal of this randomised four-period cross-over Phase I study is to asse...
Status
Completed
Location
CMAX
Start Date
2023-09-08
Trial ID
NCT05857384
Treatments Being Tested
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Completed
Location
Investigator Site
Start Date
2015-10-01
Trial ID
NCT02571855
Treatments Being Tested
2 different formulations of tafamidis will be compared under both fed and f...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2017-09-29
Trial ID
NCT03280173
Treatments Being Tested
The goal of this prospective comparative interventional study is to evaluat...
Status
Completed
Location
Kamal Al-Samarrai Specialized Hospital
Start Date
2025-07-01
Trial ID
NCT07723443
Treatments Being Tested
Study to characterize the bioequivalence of a 12.2 mg free acid tablets com...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2020-09-17
Trial ID
NCT04575116
Treatments Being Tested
All subjects in this study will be given tafamidis. After swallowing a sing...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-05
Trial ID
NCT02189330
The purpose of this study is to examine the rise in plasma Beta-hydroxy-bet...
Status
Completed
Location
Iowa State University
Start Date
2013-05
Trial ID
NCT01914952
Treatments Being Tested